Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries United Therapeutic (NQ: UTHR ) 363.55 +3.33 (+0.92%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about United Therapeutic < Previous 1 2 3 4 5 6 Next > Want To Copy 'Master Trader' Nancy Pelosi's Investments? There's An ETF For That. Here Are The Holdings February 07, 2023 Subversive Capital launched two new ETFs Tuesday that offer investors the chance to mirror the trades being made by members of Congress. Via Benzinga Analyst Ratings for United Therapeutics January 11, 2023 Via Benzinga 3 Biotech Companies to Watch in 2023 January 06, 2023 These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year. Via InvestorPlace Crocs, Lamb Weston And These 3 Stocks Insiders Are Selling January 06, 2023 The Nasdaq Composite dropped around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades. Via Benzinga Alphabet And These 2 Healthcare Stocks Insiders Are Selling January 04, 2023 The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades. Via Benzinga Morgan Stanley Maintains Overweight Rating for United Therapeutics: Here's What You Need To Know December 06, 2022 Via Benzinga Expert Ratings for United Therapeutics December 05, 2022 Via Benzinga 6 Analysts Have This to Say About United Therapeutics December 05, 2022 Via Benzinga United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease September 20, 2022 Via Benzinga Should SMLF Be On Your Investing Radar? December 26, 2022 Sitting at a market capitalization below $2 billion, small cap companies tend to be high-potential stocks compared to their large and mid-cap counterparts but come with higher risks. Via Talk Markets Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 10 December 10, 2022 What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Dec. 5-9, 2022. Via Talk Markets Our 7 Top Biotech Stock Picks for 2023 December 09, 2022 Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023. Via InvestorPlace United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday November 03, 2022 U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga United Therapeutics: Return On Capital Employed Overview August 08, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 December 06, 2022 Via Benzinga Recap: United Therapeutics Q3 Earnings November 02, 2022 United Therapeutics (NASDAQ:UTHR) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022 December 05, 2022 Via Benzinga United Therapeutics Posts Data From Remodulin Induction Before Orenitram Therapy In High Blood Pressure Patients October 31, 2022 Via Benzinga Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday November 03, 2022 Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. Via Benzinga Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session November 02, 2022 Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results. Via Benzinga Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market October 05, 2022 Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks. Via InvestorPlace Earnings Scheduled For November 2, 2022 November 02, 2022 Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022 October 11, 2022 Upgrades Via Benzinga Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review August 05, 2022 The Nasdaq and small caps rose while the S&P 500 is hitting resistance. Via Investor's Business Daily Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial August 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Outlook For United Therapeutics August 02, 2022 United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that United... Via Benzinga 7 Best Pharmaceutical Stocks to Buy Now July 20, 2022 These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world. Via InvestorPlace Swing Trading Stock Watchlist For The Week Of July 11 And Beyond July 09, 2022 The stock market's health is improving, but a likely bottom has not been confirmed yet. That means I’m buying some stocks (swing trades), but I'm not loading up yet. Let's see what I'm looking at. Via Talk Markets 7 Biotech Stocks With Key Catalysts Coming in July June 27, 2022 Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth. Via InvestorPlace Buy These 3 Low-Beta Stocks To Sail Through A Choppy Market June 25, 2022 Creating a portfolio of low-beta stocks is of utmost importance since the securities will deliver healthy returns and provide a shield against volatile market conditions. Via Talk Markets < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.